cvi42 Auto Imaging
Overview
cvi42 Auto Imaging is an advanced software as a medical device (SaMD) developed by Circle Cardiovascular Imaging, designed for the comprehensive viewing, post-processing, qualitative, and quantitative evaluation of cardiovascular Magnetic Resonance (MR) and Computed Tomography (CT) images. This AI-powered platform leverages machine learning techniques to aid in semi-automatic contouring of regions of interest, providing clinically validated tools for accurate diagnosis and seamless integration into clinical workflows. It supports physicians in confirming the presence or absence of lesions in blood vessels, evaluating and documenting such lesions, and performing calcium scoring. The software aims to improve patient throughput, accuracy, and reproducibility by optimizing decision-making with its cutting-edge AI, reducing clerical workload, and enhancing reporting efficiency.
The platform is a vendor-neutral solution, compatible with various scanning platforms and existing systems like PACS/VNA, EMR, DICOM, and HL7, making it adaptable to diverse imaging environments. It is utilized globally in over 1700 hospitals across more than 90 countries, including top medical centers, for both clinical and research purposes. Recent advancements include cvi42 | Plaque, an AI-enabled, on-premise solution for comprehensive coronary plaque analysis, further enhancing diagnostic precision and risk stratification for coronary artery disease.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-enabled automated contouring and segmentation
- Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain)
- Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment)
- Vascular CT analysis (diagnosis, planning, surveillance)
- Quantitative analysis (volume, mass, function, signal intensity, plaque)
- 3D visualization and multiplanar reconstruction (MPR)
- Simplified and smart reporting with infographics and CAD-RADS classification
- Multi-modality support (MR, CT) and vendor-neutral compatibility
- Data import/export capabilities
- Seamless integration with PACS/VNA, EMR, DICOM, HL7
Use Cases
- Diagnostic reporting for coronary artery disease, structural heart disease, and heart failure
- Quantitative assessment of cardiac images and adjacent vessels
- Coronary plaque analysis (volume, burden, composition, distribution)
- Endovascular procedure planning and post-treatment surveillance
- Clinical studies and academic research (e.g., Strain Analysis, T1/T2 Mapping, 4D Flow)
- Improving workflow efficiency and standardizing reporting in cardiac imaging labs and hospitals
What Physicians Need to Know
Leverage cvi42 Auto Imaging's AI-powered automation for rapid, reproducible, and accurate quantification of cardiac MR and CT studies, enhancing diagnostic confidence and streamlining workflows. The on-premise solution ensures data control and potentially faster turnaround times for critical assessments like coronary plaque analysis and ventricular function. Utilize the comprehensive reporting features, including CAD-RADS classification, for standardized communication and personalized patient care planning.
cvi42 is designed for seamless integration into existing clinical workflows, supporting DICOM standard format and offering HL7 integration for reporting. It is compatible with major vendor systems (e.g., GE Healthcare, Siemens Healthineers) and has expanded its capabilities through collaboration with Astute Imaging for AI-driven vascular CT analysis, providing a unified platform for cardiac, vascular, and structural heart analysis.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing |
Contact for pricing
|
| Deployment | On-premise, Stand-alone, Networked environment. Cloud compatibility is mentioned as a feature, but recent FDA clearances for modules like cvi42 | Plaque emphasize on-premise deployment for data control. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated cvi42 Auto Imaging Software Application (K213998) was cleared by the FDA on July 28, 2022, as a software as a medical device (SaMD) for viewing, post-processing, qualitative and quantitative evaluation of cardiovascular MR and CT images. Additionally, cvi42 | Plaque received 510(k) clearance on October 29, 2025, for AI-powered, on-premise coronary plaque analysis. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Radiology, Vascular Surgery |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate cvi42 Auto Imaging
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for cvi42 Auto Imaging.
cvi42 2019
Circle CVI
Frequently Asked Questions
Compare cvi42 Auto Imaging
VS
VS
VS
VS








